Geraniol, alone and in combination with pioglitazone, ameliorates fructose-induced metabolic syndrome in rats via the modulation of both inflammatory and oxidative stress status

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Ibrahim, Sherehan M ^a   El Denshary, Ezzedin S ^a   Abdallah, Dalaal M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINOTRANSFERASE; FREE RADICAL; FRUCTOSE; GERANIOL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 1BETA; LIPID PEROXIDE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; THIOL DERIVATIVE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; 2,4 THIAZOLIDINEDIONE DERIVATIVE; REACTIVE NITROGEN SPECIES; TERPENE; TUMOR NECROSIS FACTOR; URIC ACID;

ABDOMINAL OBESITY; ADIPONECTIN BLOOD LEVEL; ADIPOSE TISSUE; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT DISORDER; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCEMIC INDEX; HYPERINSULINEMIA; HYPERTENSION; HYPERURICEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTERLEUKIN 1BETA BLOOD LEVEL; LIPID PEROXIDE BLOOD LEVEL; MALE; METABOLIC SYNDROME X; MONOTHERAPY; NITRIC OXIDE BLOOD LEVEL; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TUMOR NECROSIS FACTOR ALPHA BLOOD LEVEL; WEIGHT GAIN; ANIMAL; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CHEMICALLY INDUCED; DRUG EFFECTS; DRUG INTERACTION; GENETIC TRANSCRIPTION; GENETICS; HOMEOSTASIS; LIVER; METABOLISM; OBESITY; PATHOLOGY; WISTAR RAT;

RATTUS;

ADIPONECTIN; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DRUG INTERACTIONS; FRUCTOSE; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; INFLAMMATION; INTERLEUKIN-1BETA; LIVER; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PPAR GAMMA; RATS; RATS, WISTAR; REACTIVE NITROGEN SPECIES; TERPENES; THIAZOLIDINEDIONES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; URIC ACID;

EID: 84922970134     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117516     Document Type: Article

References (75)

1. Popkin BM (2010) Patterns of beverage use across the lifecycle. Physiol Behav 100: 4-9. doi: 10.1016/j.physbeh.2009.12.022 PMID: 20045423
2. Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, et al. (2010) Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 33: 2477-2483. doi: 10.2337/dc10-1079 PMID: 20693348
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 13: 322-327. PMID: 16708441
4. Grundy SM (2006) Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr 83: 1248-1251. PMID: 16762931
5. Galassetti P (2012) Inflammation and oxidative stress in obesity, metabolic syndrome, and diabetes. Exp Diabetes Res 2012: 943706. doi: 10.1155/2012/943706 PMID: 23319940
6. Ridker PM, Wilson PW, Grundy SM (2004) Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109: 2818-2825. PMID: 15197153
7. Heinig M, Johnson RJ (2006) Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med 73: 1059-1064. PMID: 17190309
8. Brunzell JD, Ayyobi AF (2003) Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med 115: 24S-28S. PMID: 14678862
9. Robins SJ, Rubins HB, Faas FH, Schaefer EJ, Elam MB, et al. (2003) Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care 26: 1513-1517. PMID: 12716814
10. Vieira A, Heidor R, Cardozo MT, Scolastici C, Purgatto E, et al. (2011) Efficacy of geraniol but not of beta-ionone or their combination for the chemoprevention of rat colon carcinogenesis. Braz J Med Biol Res 44: 538-545. PMID: 21445532
11. Desiderio JG, Newmark H, Cook TJ (2005) Preliminary oral pharmacokinetics of the potential chemopreventive agents farnesol and geraniol. The 37th Middle Atlantic Regional Meeting (684).
12. Chadha A, Madyastha KM (1984) Metabolism of geraniol and linalool in the rat and effects on liver and lung microsomal enzymes. Xenobiotica 14: 365-374. PMID: 6475100
13. Tiwari M, Kakkar P (2009) Plant derived antioxidants - Geraniol and camphene protect rat alveolar macrophages against t-BHP induced oxidative stress. Toxicol In Vitro 23: 295-301. doi: 10.1016/j.tiv.2008.12.014 PMID: 19135518
14. Su YW, Chao SH, Lee MH, Ou TY, Tsai YC (2010) Inhibitory effects of citronellol and geraniol on nitric oxide and prostaglandin E(2)production in macrophages. Planta Med 76: 1666-1671. doi: 10.1055/s-0030-1249947 PMID: 20506077
15. Marcuzzi A, Crovella S, Pontillo A (2011) Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency. In Vivo 25: 87-92. PMID: 21282739
16. Abe S, Maruyama N, Hayama K, Ishibashi H, Inoue S, et al. (2003) Suppression of tumor necrosis factor-alpha-induced neutrophil adherence responses by essential oils. Mediators Inflamm 12: 323-328. PMID: 14668091
17. Carnesecchi S, Bradaia A, Fischer B, Coelho D, Scholler-Guinard M, et al. (2002) Perturbation by geraniol of cell membrane permeability and signal transduction pathways in human colon cancer cells. J Pharmacol Exp Ther 303: 711-715. PMID: 12388655
18. Jayachandran M, Chandrasekaran B, Namasivayam N (2015) Effect of geraniol, a plant derived monoterpene on lipids and lipid metabolizing enzymes in experimental hyperlipidemic hamsters. Mol Cell Biochem 398: 39-53. doi: 10.1007/s11010-014-2203-3 PMID: 25218494
19. Katsukawa M, Nakata R, Koeji S, Hori K, Takahashi S, et al. (2011) Citronellol and geraniol, components of rose oil, activate peroxisome proliferator-activated receptor alpha and gamma and suppress cyclooxygenase-2 expression. Biosci Biotechnol Biochem 75: 1010-1012. PMID: 21597168
20. Tjokroprawiro A (2006) New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer). Acta Med Indones 38: 160-166. PMID: 17119268
21. Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, et al. (2003) Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes 52: 1364-1370. PMID: 12765945
22. Chiquette E, Ramirez G, Defronzo R (2004) A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors. Arch Intern Med 164: 2097-2104. PMID: 15505122
23. Yki-Jarvinen H (2004) Thiazolidinediones. N Engl J Med 351: 1106-1118. PMID: 15356308
24. Khan MA, St Peter JV, Xue JL (2002) A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone. Diabetes Care 25: 708-711. PMID: 11919129
25. Tham DM, Wang YX, Rutledge JC (2003) Modulation of vascular inflammation by PPARs. Drug News Perspect 16: 109-116. PMID: 12792672
26. DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194. PMID: 2044434
27. Mahmoud AA, Elshazly SM (2014) Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats. PLoS One 9: e106993. doi: 10.1371/journal.pone.0106993 PMID: 25202970
28. Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobal M, et al. (2007) Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292: F423-F429. PMID: 16940562
29. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, et al. (2001) Diagnosing insulin resistance in the general population. Diabetes Care 24: 460-464. PMID: 11289468
30. Ong TP, Heidor R, de CA, Dagli ML, Moreno FS (2006) Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis 27: 1194-1203. PMID: 16332721
31. Majithiya JB, Paramar AN, Balaraman R (2005) Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats. Cardiovasc Res 66: 150-161. PMID: 15769458
32. El-Abhar HS, Schaalan MF (2012) Topiramate-induced modulation of hepatic molecular mechanisms: an aspect for its anti-insulin resistant effect. PLoS One 7: e37757. doi: 10.1371/journal.pone.0037757 PMID: 22649556
33. Psyrogiannis A, Kyriazopoulou V, Symeonidis A, Leotsinidis M, Vagenakis AG (2003) Relative iron "overload" in offspring of patients with type 2 diabetes mellitus: a new component in the conundrum of insulin resistance syndrome? Hormones (Athens) 2: 161-168. PMID: 17003017
34. Elmazar MM, El-Abhar HS, Schaalan MF, Farag NA (2013) Phytol/Phytanic acid and insulin resistance: potential role of phytanic acid proven by docking simulation and modulation of biochemical alterations. PLoS One 8: e45638. doi: 10.1371/journal.pone.0045638 PMID: 23300941
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. PMID: 3899825
36. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410. PMID: 10902785
37. Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86: 271-278. PMID: 655387
38. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77. PMID: 13650640
39. Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5: 62-71. PMID: 11178938
40. Wang G, Han D, Zhang Y, Xie X, Wu Y, Li S, Li M (2013) A novel hypothesis: up-regulation of HO-1 by activation of PPARgamma inhibits HMGB1-RAGE signaling pathway and ameliorates the development of ALI/ARDS. J Thorac Dis 5: 706-710. doi: 10.3978/j.issn.2072-1439.2013.08.69 PMID: 24255785
41. Schmidt AM, Yan SD, Wautier JL, Stern D (1999) Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84: 489-497. PMID: 10082470
42. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, et al. (2000) The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 275: 25781-25790. PMID: 10829018
43. Abate N (2000) Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 14: 154-174. PMID: 10989324
44. Emanuelli B, Glondu M, Filloux C, Peraldi P, Van OE (2004) The potential role of SOCS-3 in the interleukin-1beta-induced desensitization of insulin signaling in pancreatic beta-cells. Diabetes 53: S97-S103. PMID: 15561930
45. Albright AL, Johnson PR, Greene S, Stern JS (1994) Use of glycated hemoglobin to assess Glycemic control in Wistar diabetic fatty rats and Zucker fatty rats. Obes Res 2: 535-539. PMID: 16358402
46. Jack MM, Ryals JM, Wright DE (2012) Protection from diabetes-induced peripheral sensory neuropathy-a role for elevated glyoxalase I? Exp. Neurol. 234(1), 62-69. doi: 10.1016/j.expneurol.2011.12.015 PMID: 22201551
47. Koyama H, Yamamoto H, Nishizawa Y (2007) Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases. Biomark Insights 2: 331-339. PMID: 19662215
48. Ahmed N (2005) Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 67: 3-21. PMID: 15620429
49. Singh BK, Tripathi M, Chaudhari BP, Pandey PK, Kakkar P (2012) Natural terpenes prevent mitochondrial dysfunction, oxidative stress and release of apoptotic proteins during nimesulide-hepatotoxicity in rats. PLoS One 7: e34200. doi: 10.1371/journal.pone.0034200 PMID: 22509279
50. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, et al. (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 1889-1895. PMID: 12031978
51. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, et al. (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52: 1655-1663. PMID: 12829629
52. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295. PMID: 12368907
53. Liang H, Yin B, Zhang H, Zhang S, Zeng Q, et al. (2008) Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced obesity and insulin resistance. Endocrinology 149: 2943-2951. doi: 10.1210/en.2007-0978 PMID: 18339717
54. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, et al. (2002) Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51: 1884-1888. PMID: 12031977
55. Spruss A, Kanuri G, Uebel K, Bischoff SC, Bergheim I (2011) Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice. Antioxid Redox Signal 14: 2121-2135. doi: 10.1089/ars.2010.3263 PMID: 21083420
56. Xie QW, Kashiwabara Y, Nathan C (1994) Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-4708. PMID: 7508926
57. de Carvalho KI, Bonamin F, Dos Santos RC, Perico LL, Beserra FP, et al. (2014) Geraniol-a flavoring agent with multifunctional effects in protecting the gastric and duodenal mucosa. Naunyn Schmiedebergs Arch Pharmacol 387: 355-365. doi: 10.1007/s00210-013-0947-z PMID: 24337826
58. Desai RV, Ahmed MI, Fonarow GC, Filippatos GS, White M, et al. (2010) Effect of serum insulin on the association between hyperuricemia and incident heart failure. Am J Cardiol 106: 1134-1138. doi: 10.1016/j.amjcard.2010.06.023 PMID: 20920653
59. Sanchez-Lozada LG, Soto V, Tapia E, Avila-Casado C, Sautin YY, et al. (2008) Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 295: F1134-F1141. doi: 10.1152/ajprenal.00104.2008 PMID: 18701632
60. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, et al. (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739-1742. PMID: 15840020
61. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ (2007) Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 293: C584-C596. PMID: 17428837
62. Hirsch J (1995) Role and benefits of carbohydrate in the diet: key issues for future dietary guidelines. Am J Clin Nutr 61: 996S-1000S. PMID: 7900699
63. Fried SK, Rao SP (2003) Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr 78: 873S-880S. PMID: 14522752
64. Wisse BE (2004) The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15: 2792-2800. PMID: 15504932
65. Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, et al. (2002) Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 10: 1095-1103. PMID: 12429872
66. Tsuchida A, Yamauchi T, Takekawa S, Hada Y, Ito Y, et al. (2005) Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPAR alpha, PPAR gamma, and their combination. Diabetes 54: 3358-3370. PMID: 16306350
67. Gutierrez DA, Puglisi MJ, Hasty AH (2009) Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Curr Diab Rep 9: 26-32. PMID: 19192421
68. Bartolome N, Rodriguez L, Martinez MJ, Ochoa B, Chico Y (2007) Upregulation of apolipoprotein B secretion, but not lipid, by tumor necrosis factor-alpha in rat hepatocyte cultures in the absence of extracellular fatty acids. Ann N Y Acad Sci 1096: 55-69. PMID: 17405916
69. Qin B, Anderson RA, Adeli K (2008) Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling. Am J Physiol Gastrointest. Liver Physiol 294: G1120-G1129. doi: 10.1152/ajpgi.00407.2007 PMID: 18372392
70. Qin B, Qiu W, Avramoglu RK, Adeli K (2007) Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins. Diabetes 56: 450-461. PMID: 17259391
71. Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV (2004) Effect of alpha-lipoic acid on lipid profile in rats fed a high-fructose diet. Exp Diabesity Res 5: 195-200. PMID: 15512787
72. Durstine JL, Haskell WL (1994) Effects of exercise training on plasma lipids and lipoproteins. Exerc Sport Sci Rev 22: 477-521. PMID: 7925552
73. Srinivasan K, Patole PS, Kaul CL, Ramarao P (2004) Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol 26: 327-333. PMID: 15319810
74. Yuan GJ, Zhang ML, Gong ZJ (2004) Effects of PPAR gamma agonist pioglitazone on rat hepatic fibrosis. World J Gastroenterol 10: 1047-1051. PMID: 15052691
75. Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, et al. (2013) PPAR gamma signaling and metabolism: the good, the bad and the future. Nat Med 19: 557-566. doi: 10.1038/nm.3159 PMID: 23652116